Home | Phase III study of the Cuban vaccine candidate VCN7-T in patients from 1 to 18 years of age at risk of pneumococcal disease in Havana

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials Phase III study of the Cuban vaccine candidate VCN7-T in patients from 1 to 18 years of age at risk of pneumococcal disease in Havana has 3 revisions.
RevisionStatus
Saved 05/10/2023 - 10:07am by FINLAY
current revision (published)
Saved 05/10/2023 - 9:44am by FINLAY
archived
Saved 04/10/2023 - 12:11pm by FINLAY
archived